MedTrace Logo

Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence

NCT02226185 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1108

Last updated 2019-03-26

No results posted yet for this study

Summary

Berberine hydrochloride is a conventional component in Chinese medicine. In recent years, anticancer activity of berberine hydrochloride have been explored. The aim of this study is to investigate the effect of berberine hydrochloride on the recurrence of colorectal adenomas.

Conditions

  • Colorectal Adenoma

Interventions

DRUG

Berberine hydrochloride

supplement of Berberine hydrochloride 0.3g two times per day for 2-3 years

DRUG

placebo

supplement of placebo two times per day for 2-3 years

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Jing-Yuan Fang, M.D., Ph.D · Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2018-12-29
Completion
2018-12-29

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02226185 on ClinicalTrials.gov